Vera Therapeutics (VERA) Stock Research

Today

Vera Therapeutics reports Q3 EPS ($1.52), consensus ($1.59)

VERA

5:03 PM

Over a week ago

Vera chief regulatory officer William Turner to retire, Nancy Boman to succeed

Jul 9, 8:22 AM

Vera Therapeutics price target raised by $20 at Guggenheim, here's why

VERA

Jul 8, 9:14 AM

Vera Therapeutics price target raised by $5 at TD Cowen, here's why

VERA

Jul 8, 8:12 AM

Vera Therapeutics price target raised by $8 at Wedbush, here's why

VERA

Jul 8, 7:51 AM

Vera Therapeutics price target raised by $15 at H.C. Wainwright, here's why

VERA

Jul 8, 6:27 AM

Vera Therapeutics price target raised by $5 at BofA, here's why

VERA

Jul 7, 2:09 PM

Vera's Trutakna approved by FDA for adults with primary IgA nephropathy

VERA

Jul 7, 12:28 PM

Raymond James sees unique buying opportunity in Vera after FDA alignment

VERA

Jun 2, 11:50 AM

Vera Therapeutics announces alignment with FDA on earlier ORIGIN 3 eGFR analysis

VERA

Jun 2, 11:47 AM

Vera Therapeutics price target lowered by $4 at Evercore ISI

VERA

May 15, 8:25 AM

Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)

VERA

May 7, 8:53 AM

Vera Therapeutics just upgraded at Wolfe Research, here's why

Mar 10, 7:00 PM

Vertex poses 'no threat' to Vera Therapeutics' atacicept, says BofA

Mar 10, 7:56 AM

Vera Therapeutics appoints Hite to Board of Directors

VERA

Mar 5, 9:10 AM

Vera Therapeutics price target raised by $20 at H.C. Wainwright, here's why

VERA

Mar 2, 6:07 AM

Vera Therapeutics sees cash runway through atacicept commercial launch

VERA

Feb 26, 7:35 AM

Vera Therapeutics reports FY25 EPS ($4.66), consensus ($4.44)

VERA

Feb 26, 7:35 AM

Vera Therapeutics appoints Skelton as Chief Commercial Officer

VERA

Jan 28, 7:34 AM

Vera Therapeutics announces atacicept BLA accepted for Priority Review by FDA

VERA

Jan 7, 7:31 AM

Wolfe upgrades Vertex Pharmaceuticals, says 'may be due for a rebound'

Jan 6, 7:59 AM

Short Report: Vera Therapeutics bears retreat as stock rallies

Dec 21, 6:48 PM

Vera Therapeutics price target raised by $18 at BofA, here's why

VERA

Dec 19, 7:33 AM

Vera Therapeutics price target raised by $40 at Goldman Sachs, here's why

VERA

Dec 19, 7:20 AM

Vera Therapeutics price target lowered by $3 at JPMorgan, here's why

VERA

Dec 19, 6:56 AM

Today

Vera Therapeutics reports Q3 EPS ($1.52), consensus ($1.59)

VERA

5:03 PM

Over a week ago

Vera chief regulatory officer William Turner to retire, Nancy Boman to succeed

Jul 9, 8:22 AM

Vera Therapeutics price target raised by $20 at Guggenheim, here's why

VERA

Jul 8, 9:14 AM

Vera Therapeutics price target raised by $5 at TD Cowen, here's why

VERA

Jul 8, 8:12 AM

Vera Therapeutics price target raised by $8 at Wedbush, here's why

VERA

Jul 8, 7:51 AM

Vera Therapeutics price target raised by $15 at H.C. Wainwright, here's why

VERA

Jul 8, 6:27 AM

Vera Therapeutics price target raised by $5 at BofA, here's why

VERA

Jul 7, 2:09 PM

Vera's Trutakna approved by FDA for adults with primary IgA nephropathy

VERA

Jul 7, 12:28 PM

Raymond James sees unique buying opportunity in Vera after FDA alignment

VERA

Jun 2, 11:50 AM

Vera Therapeutics announces alignment with FDA on earlier ORIGIN 3 eGFR analysis

VERA

Jun 2, 11:47 AM

Vera Therapeutics price target lowered by $4 at Evercore ISI

VERA

May 15, 8:25 AM

Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)

VERA

May 7, 8:53 AM

Vera Therapeutics just upgraded at Wolfe Research, here's why

Mar 10, 7:00 PM

Vertex poses 'no threat' to Vera Therapeutics' atacicept, says BofA

Mar 10, 7:56 AM

Vera Therapeutics appoints Hite to Board of Directors

VERA

Mar 5, 9:10 AM

Vera Therapeutics price target raised by $20 at H.C. Wainwright, here's why

VERA

Mar 2, 6:07 AM

Vera Therapeutics sees cash runway through atacicept commercial launch

VERA

Feb 26, 7:35 AM

Vera Therapeutics reports FY25 EPS ($4.66), consensus ($4.44)

VERA

Feb 26, 7:35 AM

Vera Therapeutics appoints Skelton as Chief Commercial Officer

VERA

Jan 28, 7:34 AM

Vera Therapeutics announces atacicept BLA accepted for Priority Review by FDA

VERA

Jan 7, 7:31 AM

Wolfe upgrades Vertex Pharmaceuticals, says 'may be due for a rebound'

Jan 6, 7:59 AM

Short Report: Vera Therapeutics bears retreat as stock rallies

Dec 21, 6:48 PM

Vera Therapeutics price target raised by $18 at BofA, here's why

VERA

Dec 19, 7:33 AM

Vera Therapeutics price target raised by $40 at Goldman Sachs, here's why

VERA

Dec 19, 7:20 AM

Vera Therapeutics price target lowered by $3 at JPMorgan, here's why

VERA

Dec 19, 6:56 AM

Company News

Charts